University of Colorado School of Medicine: Barbara Davis Center for Diabetes
Welcome,         Profile    Billing    Logout  
 8 Trials 
5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Gottlieb, Peter
MER3101, NCT03624062: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes

Recruiting
1
28
US
MAS-1 adjuvanted Insulin B-chain
University of Colorado, Denver, The Leona M. and Harry B. Helmsley Charitable Trust, Nova Immunotherapeutics Limited
Type 1 Diabetes Mellitus
12/25
12/25
Esrey, Trudy
DIAGNODE-3, NCT05018585 / 2021-002731-32: A Phase III Study to Investigate If the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed with Type 1 Diabetes

Recruiting
3
330
Europe, US, RoW
Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®, Diamyd, Colecalciferol 2000 IU, Divisun 2000 IU, Placebo
Diamyd Medical AB
Type 1 Diabetes Mellitus
12/27
12/27
NCT05743244: Janus Kinase (JAK) Inhibitors to Preserve C-Peptide Production in New Onset Type 1 Diabetes (T1D)

Recruiting
2
78
US
Abrocitinib 200 MG Oral Tablet, CIBINQO, Ritlecitinib, Placebo
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Pfizer
Diabetes Mellitus, Type 1
06/26
06/27
TOPPLE T1D, NCT04279613: A Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of NNC0361-0041

Completed
1
47
US
NNC0361-0041, Placebo
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Novo Nordisk A/S
Type I Diabetes
08/23
04/24
Broncucia, Hali
MER3101, NCT03624062: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes

Recruiting
1
28
US
MAS-1 adjuvanted Insulin B-chain
University of Colorado, Denver, The Leona M. and Harry B. Helmsley Charitable Trust, Nova Immunotherapeutics Limited
Type 1 Diabetes Mellitus
12/25
12/25

Download Options